Brain resident and infiltrating innate immune cells adapt a tumor-supportive phenotype in the 14 glioma microenvironment. Flow cytometry analysis supported by a single-cell RNA 15 sequencing study of human gliomas indicate considerable cell type heterogeneity. It remains 16 disputable whether microglia and infiltrating macrophages have the same or distinct roles in 17 supporting glioma progression. Here, we performed single-cell transcriptomics analyses of 18 CD11b+ cells sorted from murine syngeneic gliomas, indicating distinct activity of microglia, 19 infiltrating monocytes/macrophages and CNS border-associated macrophages. Our results 20 demonstrate a previously immeasurable scale of molecular heterogeneity in the innate 21 immune response in gliomas. We identified genes differentially expressed in activated 22 microglia from glioma-bearing mice of different sex, and profound overexpression of the 23 MHCII genes by male microglial cells, which we also observed in bulk human glioma 24 samples. Sex-specific gene expression in microglia in the glioma microenvironment may be 25 relevant to sex differences in incidence and outcomes of glioblastoma patients. 26 27 3 28 Introduction 29 Infiltrating immune system cells represent an abundant non-malignant component of the 30
6 genes-Ly6i, Ly6c2, macrophage genes-Ifitm3 10 -, and BAM genes-Apoe, Ms4a7, 135 Mrc1 33 . These features confirmed the identity of the distinguished cell populations ( Figure   136 2b). Microglial cell group was best characterized by the expression of Tmem119, Cx3cr1, 137 P2ry12, Gpr34, Olfml3, and Sparc (Figure 2c ). Some highly expressed microglial genes 138 were found only in a fraction of cells (e.g., the P2ry13 gene was found in less than 75% of 139 microglial cells); other microglial genes including Fcrls and Cd81 were also expressed in 140 BAMs and Hexb, and Cst3 was expressed both in BAMs and monocytes/macrophages 141 (Mo/MΦ). For Mo/MΦ, we found the specific expression of previously reported genes such 142 as Ifitm2, S100a6, and S100a11 10 , as well as novel genes, namely Lgals3, Isg15, Ms4a4c, 143 and Crip1 (Figure 2d ). Ifitm3 was highly expressed by the Mo/MΦ population, but it has been 144 found in a substantial fraction of microglial cells, showing its low specificity towards 145 monocytes/macrophages within glioma TME. Interestingly, among the highly upregulated 146 Mo/MΦ genes, we found markers characterizing discrete subpopulations of the Mo/MΦ. The 147 high Ly6c2 expression was found in a large cell fraction, which could be further divided into 148 Ly6c2 high Ccr2 high monocytes (Mo) and Ly6c2 high Tgfbi high monocyte/macrophage intermediate 149 cells (intMoMΦ) (Figure 2e-g) . The remaining cells resembled differentiated tissue 150 macrophages (MΦ because they lacked the markers of the cytotoxic monocytes Ly6c2 and 151 Ccr2 and had a strong "macrophage" signature (Ifitm2 high , S100a6 high , S100a11 high ). Notably,
152
we found a population of macrophages (MΦ) expressing a high level of Cd274 (a gene 153 coding for PD-L1, an immune checkpoint protein), and Ccl22, Ccl5, which are chemokines 154 important for T-cell recruitment 34, 35 . Such an expression pattern suggests a putative role of 155 those cells in mediating the immunosuppressive response. Additionally, macrophages highly 156 and specifically expressed Tmem123, a gene of unknown function in microglia and 157 macrophages, encoding a transmembrane protein Porimin that mediates cell death in Jurkat 158 cells 36 and is expressed in mature dendritic cells 37 .
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We also examined the expression of genes that have been recently postulated as 160 specific markers of infiltrating monocytes/macrophages within the TME of glioma: Itga4 7 , Hp, 161 Emilin2, Sell, and Gda 17 (Figure 2d ). The expression of Itga4 (CD49d) was generally low 162 and limited mostly to the MΦ subpopulation that resembles the most differentiated fraction of 163 the infiltrating macrophages and expresses a high level of Cd274 (PD-L1). Low Itga4 164 expression in our data set might be explained by an early tumor growth stage (2 weeks after 165 glioma cell implantation) and the high content of cytotoxic monocytes compared to 166 macrophages. In a previous study, samples were collected at later time-points-3 weeks 167 after implantation of GL261 cells and 5 weeks after implantation of shP53-transfected cells 7 .
168
The expression of Hp, Emilin2, Sell, Gda, the markers suggested in a recent meta-analysis 169 of bulk RNA-seq data sets and validation at RNA and protein levels 17 , was found in the 170 fraction of Mo (Ly6c2 high , Ccr2 high ). In addition, we examined the expression of Tgm2 and 7 Gpnmb, previously reported as the genes commonly upregulated by GAMs across different 172 glioma animal models and in patient-derived samples in a bulk RNA-seq meta-analysis 3 173 ( Figure 2h) . Surprisingly, their expression was limited to the small fraction of Mo/MΦ, 174 demonstrating that bulk RNA-seq results may be biased by genes expressed at a high level 175 by a small subset of cells.
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The third most abundant cell population in our data set were BAMs, marked by highly 177 expressed Apoe and Ms4a7 genes that were recently proposed as universal markers of 178 macrophages residing at the CNS borders 33 . Apoe and Ms4a7 were also expressed by 179 Mo/MΦ; however, we found other highly expressed BAM genes (Mrc1, Dab2, F13a1, Mgl2,  
180
and Pf4) to be better for identifying the BAM population (Figure 2i ). Summarizing, we 181 validated the expression of known markers at the single-cell level and obtained a good 182 agreement of selected microglia and BAM markers in our data set with literature data. In 183 contrast, Mo/MΦ showed substantial heterogeneity that is likely related to their differentiation 184 state. We identified genes characterizing the specific monocyte/macrophage subpopulations. 
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Using microglia and Mo/MΦ scores (defined as an average of expression levels of 200 genes specific to and highly expressed in a given population) (Figure 3b ), we examined 201 whether the glioma microenvironment alters expression profiles of microglia and macrophage 202 "signature" genes (see for details Supplementary Table 1 ). We noticed a shift towards the 203 lower "microglia signature" score in MG from the tumor-bearing brains compared to MG from 
211
Previous reports demonstrated that microglia occupy predominantly the tumor 212 periphery, whereas infiltrating monocytes/macrophages are found mostly within the tumor 213 core 9,38 Using double immunostaining, we demonstrate that microglia (Tmem119+, Iba1+) 
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Altogether, we show that microglia undergo glioma-induced activation reflected by 218 upregulation of a number of genes related to cytokine signaling and extracellular matrix 219 degradation. This activation was associated with the slight downregulation in the expression 220 of "microglia signature" genes. Both microglia and monocytes/macrophages retain their cell 221 identity within the TME, and the differential expression of microglia and macrophage-specific 222 genes allows for a clear distinction between these cells. growth. To answer this question, we examined whether MG and Mo/MΦ activate common 229 or distinct transcriptional networks. We performed this differential expression analysis in two 230 steps. Firstly, we extracted genes highly upregulated in microglial cells from glioma-bearing 231 brains (significantly upregulated genes in Act-MG compared to Hom-MG) (Figure 4a ).
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Subsequently, we performed the same analysis for Act-MG and Mo/MΦ cells (Figure 4b ).
233
This work allowed us to find genes either common or specific for each subpopulation ( Figure   234 4c,d). We found that the majority of genes upregulated in the Act-MG are also expressed by 235 Mo/MΦ, and their expression is usually higher in Mo/MΦ than Act-MG ( Figure 4c ). Among 236 commonly induced genes, we found Ifitm3 and a group of genes encoding MHCII proteins;
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Ifitm3 has been reported as a gene, the expression of which demarcates macrophages from 238 microglia 10 . We found that Ifitm3 was indeed highly expressed in monocytes/macrophages; 239 however, its expression was also induced in glioma-activated microglia, although at the lower 240 level (Figure 4c, d) . Besides commonly upregulated genes, we also found population-241 specific expression patterns. Act-MG showed a high expression of Ccl3, Ccl4, and Ccl12 (the 242 9 chemokine-encoding genes), whereas their expression was lower in Mo/MΦ. In contrast,
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Mo/MΦ were characterized by the high expression of Ifitm2 and Ccl5 genes (Figure 4c ).
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Next, we performed a Gene Ontology (GO) analysis of biological processes on the 245 two sets of genes-genes significantly upregulated in Act-MG compared to Hom-MG ( Figure   246 4e) and genes significantly upregulated in Mo/MΦ compared to the Act-MG (Figure 4f ). We 247 found that the glioma-induced expression in MG was specifically enriched in genes related to 248 "cytoplasmic translation" that encode ribosomal proteins, whereas in Mo/MΦ we found 249 specific enrichment in genes related to "drug metabolic process" and "purine monophosphate 250 metabolic process". All other terms were directly related to the immune function and were 251 largely shared between the genes up-regulated in MG and Mo/MΦ. Both populations showed 252 induction of genes related to "response to bacterium" and "response to interferon-gamma"; 253 however, those terms encompassed the broader number of genes for Mo/MΦ. In addition,
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Mo/MΦ demonstrated the more pronounced activation of the interferon-related genes 255 because we also identified enrichment of "response to interferon-beta" genes. The genes 256 related to the term "antigen processing and presentation" appeared only in Act-MG; however, 257 the majority of genes contained within this term code for the MHCII protein complex, and are 258 also upregulated in Mo/MΦ.
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There are some shared genes that are expressed at a high level in Mo/MΦ compared Sex is an important prognostic marker in GBM patients influencing incidence and disease 278 outcomes 11, 42 . Differences between male and female microglia in naïve mice have been 279 reported 13, 14 . Thus, we sought to determine whether there are sex-related differences in the 280 expression of genes in myeloid populations within the TME. Importantly, the unsupervised 281 cell clustering showed that microglia from glioma-bearing brains, but not from naïve brains, 282 segregate into clusters that are enriched either in cells originating from female or male brains 283 (Figure 5a, Supplementary Figure 4a) . Similarly, we noticed the sex-driven cell clustering 284 within the intMoMΦ subpopulation of monocytes/macrophages, pointing to differences in 285 immune cell activation in male and female mice (Figure 5a, Supplementary Figure 4b ).
286
The search for differentially expressed genes revealed that in Act-MG from males, the 287 most highly upregulated genes are the genes coding for MHCII (H2-Ab1, H2-Eb1, H2-Aa) 288 and Cd74-encoding an invariant MHCII chain that regulates folding and trafficking of the 289 MHCII proteins (Figure 5b) . The increased expression of the MHCII genes and Cd74 290 colocalizes with the male-dominated cell clusters found in the Act-MG, but also in the 291 intMoMΦ population (Figure 5c ). This co-localization was not observed in naïve mice 292 (Figure 5d) . Accordingly, the cells with the high expression of MHCII and Cd74 genes were 293 enriched in Act-MG and intMoMΦ in males. This enrichment was not observed in other 294 subpopulations: Hom-MG, Mo, MΦ, and BAMs (Figure 5d ). Moreover, intMoMΦ in males 295 upregulated Mif, encoding a macrophage migration inhibitory factor, an inflammatory 296 cytokine that binds with a high affinity to CD74, inducing a pro-inflammatory response and 297 CCL2-mediated macrophage migration and cell proliferation 43, 44 . The increased expression of 298 Mif in cells with the high expression of MHCII genes was restricted to the intMoMΦ 299 subpopulation and not detected in the Act-MG (Figure 5e ). This observation suggests that 300 although high expression of MHCII genes is found in males in both glioma-activated 301 microglia and a substantial fraction of infiltrating monocytes/macrophages, it may exert 302 different effects in those two cell populations. The flow cytometry analysis run on the same 303 cell pool, which was used to perform with the scRNA-seq, showed an elevated number of 304 CD4+ T-cells in tumor-bearing hemispheres from males compared to females. (Figure 5f ).
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We explored the human glioma expression data from The Cancer Genome Atlas (TCGA) to 306 determine whether sex has an impact on the expression of MHCII and CD74 genes. High-307 grade glioma samples were not discriminated by the expression levels of the selected MHCII 308 and CD74 genes (data not shown), irrespective of IDH1 mutation status or macrophage 309 content as estimated with the xCell, a gene signature-based method inferring 64 immune and 310 stromal cell types 45 . However, the expression of MHCII and CD74 genes stratified glioma 311 WHO grade II patients into the female-enriched MHCII low group and the male-enriched 312 MHCII high group (Figure 5g) . This observation shows that the differential regulation of genes 313 coding for MHCII complex between sexes is not limited to a mouse glioma model, and those 314 11 differences could be of clinical relevance. Altogether, we demonstrate that transcriptional 315 responses of microglia to glioma varies between sexes, and microglia from tumor-bearing 316 brains in males exhibit more prominent antigen presentation processes compared to their 317 female counterparts.
319

Discussion
320
In the present study, we have used cell sorting and single-cell RNA sequencing to dissect the 321 cellular and functional heterogeneity of GAMs. Although it has been known that human 322 glioblastomas, the most malignant primary brain tumors, are infiltrated with resident microglia the description, all other quantitative parameters were fixed to default values. To filter out 507 possible empty droplets, low-quality cells, and possible multiplets, cells with less than 200 or 508 more than 3,000 transcripts were excluded from the analysis. Additionally, cells of poor 509 quality, recognized as cells with >5% of their transcripts coming from mitochondrial genes,
510
were excluded from the downstream analysis. After applying these filters, 40,401 cells were 511 present in the data set. Gene expression measurements for each cell were normalized by the 512 total number of transcripts in the cell, multiplied by a default scale factor, and the normalized 513 values were log-transformed ("LogNormalize" method). Following a Seurat workflow, for 514 each replicate the 2,000 most highly variable genes were identified using variance stabilizing 515 transformation ("vst"). To facilitate identification of cell types these gene sets were expanded 516 by adding genes described as having important roles in immune cells (see Supplementary   517   Table 3 ) and genes involved in cell cycle regulation 61 . This extension did not influence our 
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The comparative analysis was based on the raw counts but limited to the previously selected 537 profiles and genes (see above). For such a data set, a new set of the 2,000 most highly 538 variable genes was identified using variance stabilizing transformation ("vst"), and this set 539 was further expanded by adding the genes involved in cell cycle regulation. Computation of 540 expression estimations, regression of the unwanted variation, and data dimensionality 541 reduction were performed as described above. Next, the expression profiles were clustered 542 using the same approach as above, but with a resolution parameter set to 0.6. After 
